Abstract
Pregnant women with chronic pain require sustained pain management during the course of their pregnancy. Paracetamol (acetaminophen) and some migraine medications are generally acceptable for the management of chronic pain throughout pregnancy. However, the use of some analgesics [e.g. NSAIDs, acetylsalicylic acid (aspirin) and synthetic opioids] and adjuvant analgesics (e.g. certain anticonvulsants and antidepressants) are preferably avoided during some or all stages of pregnancy. Prenatal analgesic exposure is unlikely to have long-term effects on child development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Källen B, Reis M. Ongoing pharmacological management of chronic pain in pregnancy. Drugs. 2016;76(9):915–24.
Rebordosa C, Kogevinas M, Bech BH, et al. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int J Epidemiol. 2009;38(3):706–14.
Li D-K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:368.
Edwards DRV, Aldridge T, Baird DD, et al. Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion. Obstet Gynecol. 2012;120(1):113–22.
Daniel S, Koren G, Lunenfeld E, et al. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure. Am J Obstet Gynecol. 2015;212(3):307.e1–.e6.
Werler MM, Sheehan JE, Mitchell AA. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol. 2002;155:26–31.
Werler MM, Louik C, Mitchell AA. Epidemiological analysis of maternal factors and amniotic band defects. Birth Def Res (Part A). 2003;67(1):68–72.
Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology. 2010;21(6):779–85.
Snijder CA, Kortenkamp A, Steegers EAP, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurence of cryptorchidism and hypospadia in the offspring: the generation R study. Hum Reprod. 2012;27:1191–201.
Rebordosa C, Zelop CM, Kogevinas M, et al. Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study. J Mat-Fetal Neonatal Med. 2010;23(5):371–8.
Källen B, Nilsson E, Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine. Drug Saf. 2011;34(8):691–703.
Marchenko A, Etwel F, Olutunfese O, et al. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache. 2015;55(4):490–501.
Källen B, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17:255–63.
Antonucci R, Zaffanello M, Puxeddu E, et al. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. 2012;13:474–90.
Van Marter LJ, Hernandez-Diaz S, Werler MM, et al. Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn. Pediatrics. 2013;131:79–87.
Källen B, Reis M. Use of tramadol in early pregnancy and congenital malformation risk. Reprod Toxicol. 2015;58:246–51.
Guttoso T Jr, Shaman M, Thornburg LL. Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;181:280–3.
Källen B, Borg N, Reis M. The use of central nervous system active drugs during pregnancy. Pharmaceuticals. 2013;6(10):1221–86.
Lassen D, Ennis ZN, Damkier P. First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol. 2016;118:32–6.
De Fays L, Van Malderen K, De Smet K, et al. Use of paracetamol during pregnancy and child neurological development. Dev Med Child Neurol. 2015;57:718–24.
Baldacchino A, Arbuckle K, Petrie DJ, et al. Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:104.
Källen B, Finnström O, Nygren K-G, et al. Maternal drug use during pregnancy and asthma risk among children. Pediatr Allergy Immunol. 2013;24(1):28–32.
Rebordosa C, Kogevinas M, Horváth-Puhó E, et al. Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obst Gynecol. 2008;198:178.e1–.e7.
Author information
Authors and Affiliations
Consortia
Ethics declarations
The article was adapted from Drugs 2016;76(9):915–24 [1] by salaried employees of Adis/Springer and was not supported by any external funding.
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Manage chronic pain during pregnancy with selected analgesics. Drugs Ther Perspect 33, 62–65 (2017). https://doi.org/10.1007/s40267-016-0359-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-016-0359-5